Collectively, our findings thus demonstrate that the inhibition of IRE1 kinase activity by a small‐molecule inhibitor or genetic ablation of FMRP, its kinase substrate, in macrophages can reduce the progression of hypercholesterolemia‐induced atherosclerosis. Here, FMR1 is linked to atherosclerosis.